LASP1 抗体
(LIM and SH3 Protein 1 (LASP1))
This gene encodes a member of a subfamily of LIM proteins, characterized by a LIM motif and a domain of Src homology region 3, and also a member of the nebulin family of actin-binding proteins. The encoded protein is a cAMP and cGMP dependent signaling protein and binds to the actin cytoskeleton at extensions of the cell membrane. The encoded protein has been linked to metastatic breast cancer, hematopoetic tumors such as B-cell lymphomas, and colorectal cancer. [provided by RefSeq, Oct 2012].
recommended
recommended
LASP1 适用: 人 WB, ELISA, IHC, IP, IF 宿主: 兔 Polyclonal unconjugated
recommended
LASP1 抗体 by Grade
Find LASP1 抗体 with a specific Grade. The Grade listed below are among those available. Click on a link to go to the corresponding products.
LASP1 抗体 by 应用范围
Find LASP1 抗体 validated for a specific application such as WB, ELISA, IHC, IP. Some of the available applications are listed below. Click on a link to go to the corresponding products.
LASP1 抗体 by 抗体来源
Find LASP1 抗体 with a specific 抗体来源. The 抗体来源 listed below are among those available. Click on a link to go to the corresponding products.
LASP1 抗体 by 克隆形成能力
Find available monoclonal or polyclonal LASP1 抗体. Click on a link to go to the corresponding products.
LASP1 抗体 by 克隆
Find LASP1 抗体 with a specific 克隆. The 克隆 listed below are among those available. Click on a link to go to the corresponding products.
LASP1 抗体 by 标记
Find LASP1 抗体 with a specific conjugate such as Biotin, FITC, HRP. The conjugates listed below are among those available. Click on a link to go to the corresponding products.
Popular LASP1 抗体
Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Human
Application
WB, IP, IF
Validations
- (6)
Cat. No.
ABIN1680664
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA, IHC, IP, IF
Validations
- (4)
Cat. No.
ABIN7158350
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human, Mouse, Rat
Application
WB, IHC (p), ICC
Validations
- (5)
Cat. No.
ABIN3044177
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human, Mouse, Rat
Application
WB, IHC (p), ICC
Validations
- (5)
Cat. No.
ABIN3031619
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA, IHC
Validations
- (3)
Cat. No.
ABIN238605
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human, Mouse, Rat
Application
WB, ELISA, IHC
Validations
- (2)
Cat. No.
ABIN7252120
Quantity
200 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA
Validations
- (2)
Cat. No.
ABIN184658
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Cow, Dog, Guinea Pig, Horse, Human, Mouse, Rabbit, Rat, Zebrafish (Danio rerio)
Application
WB, IHC
Validations
- (1)
- (2)
Cat. No.
ABIN2785891
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human, Mouse
Application
WB
Validations
- (1)
Cat. No.
ABIN7260919
Quantity
200 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA
Validations
- (1)
Cat. No.
ABIN517447
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Bat, Cow, Dog, Guinea Pig, Horse, Human, Monkey, Mouse, Pig, Rat
Application
WB
Validations
- (1)
Cat. No.
ABIN6738999
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Bat, Chicken, Cow, Dog, Guinea Pig, Horse, Human, Monkey, Mouse, Rabbit, Rat, Xenopus laevis, Zebrafish (Danio rerio)
Application
WB
Validations
- (1)
Cat. No.
ABIN6738998
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human, Mouse, Rat
Application
WB
Validations
- (1)
Cat. No.
ABIN630939
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, IHC (p)
Validations
- (2)
Cat. No.
ABIN5518689
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
WB, IHC, ICC
Validations
- (2)
Cat. No.
ABIN1868910
Quantity
100 μL
Datasheet
Datasheet
Latest Publications for our LASP1 抗体
: "A complex containing LPP and α-actinin mediates TGFβ-induced migration and invasion of ErbB2-expressing breast cancer cells." in: Journal of cell science, Vol. 126, Issue Pt 9, pp. 1981-91, (2013) (PubMed).: "High density SNP association study of a major autism linkage region on chromosome 17." in: Human molecular genetics, Vol. 16, Issue 6, pp. 704-15, (2007) (PubMed).
: "Silencing of LASP-1 influences zyxin localization, inhibits proliferation and reduces migration in breast cancer cells." in: Experimental cell research, Vol. 312, Issue 7, pp. 974-82, (2006) (PubMed).
: "Organelle proteomics of rat synaptic proteins: correlation-profiling by isotope-coded affinity tagging in conjunction with liquid chromatography-tandem mass spectrometry to reveal post-synaptic ..." in: Journal of proteome research, Vol. 4, Issue 3, pp. 725-33, (2005) (PubMed).
: "Lasp-1, a novel type of actin-binding protein accumulating in cell membrane extensions." in: Molecular medicine (Cambridge, Mass.), Vol. 4, Issue 10, pp. 675-87, (1999) (PubMed).
: "E2A and E2-2 are subunits of B-cell-specific E2-box DNA-binding proteins." in: Molecular and cellular biology, Vol. 13, Issue 6, pp. 3522-9, (1993) (PubMed).
: "An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers." in: Cell, Vol. 64, Issue 2, pp. 459-70, (1991) (PubMed).
: "Identification of a pancreatic beta-cell insulin gene transcription factor that binds to and appears to activate cell-type-specific expression: its possible relationship to other cellular factors ..." in: Molecular and cellular biology, Vol. 10, Issue 4, pp. 1564-72, (1990) (PubMed).
: "A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins." in: Cell, Vol. 56, Issue 5, pp. 777-83, (1989) (PubMed).
: "Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility." in: Science (New York, N.Y.), Vol. 236, Issue 4808, pp. 1573-7, (1987) (PubMed).
Aliases for LASP1 抗体
LIM and SH3 protein 1 (lasp1) 抗体LIM and SH3 protein 1 L homeolog (lasp1.L) 抗体
LIM and SH3 protein 1 (LASP1) 抗体
LIM and SH3 protein 1 (Lasp1) 抗体
AA408629 抗体
Def-4 抗体
fb92f05 抗体
Lasp-1 抗体
lasp-1 抗体
lasp1 抗体
LASP1 抗体
MGC53336 抗体
MGC89667 抗体
MLN50 抗体
mln50 抗体
SH3P6 抗体
Tg(Col1a1-lacZ)1Ngma 抗体
wu:fb92f05 抗体
zgc:77542 抗体
您还需要查找其他产品吗？
You are here:
